Liquidia Corporation Common Stock vs Live Nation Entertainment, Inc. — how do they compare? Liquidia Corporation Common Stock trades at $33.46 (market cap $2.40B), while Live Nation Entertainment, Inc. trades at $169.98 (market cap $39.91B). The key difference: Live Nation Entertainment, Inc. is far larger — about 16.6× Liquidia Corporation Common Stock's market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Live Nation Entertainment, Inc. for 72 Days on average.
| LQDA | LYV | |
|---|---|---|
Market Cap | $2.40B | $39.91B |
Volume | 2,857,547 | 1,800,962 |
Sector | Health | Media |
52-Week High | $91.03 | $188.46 |
52-Week Low | $22.02 | $125.61 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $2.30B | $42.12B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Live Nation Entertainment (LYV) trades at $168.84, down 0.47% on the day, with a neutral technical signal. The stock shows strong analyst support with an 86.96% buy rating and a $208.64 consensus price target, implying significant upside. Recent Q2 2026 earnings beat expectations with EPS of $1.05 versus $0.66 expected, driven by robust fan attendance and record deferred revenue. However, valuation metrics remain elevated with a P/E of 117.49 and P/B of 484.76, while profitability is thin with a net income margin of 0.51%.
The outlook is cautiously optimistic given strong demand for live events and strategic expansions, but high debt levels, regulatory scrutiny, and execution risks pose challenges. Revenue growth is projected to reach $26.3 billion in 2026, though net profit margins are expected to compress to 0.51%. Investors should weigh the bullish analyst sentiment against the stock's rich valuation and operational headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →